49 related articles for article (PubMed ID: 27487812)
1. A challenging issue in COVID-19 infection: The relationship between PA1-1 and TAFI levels in patients with coagulation disorder: A retrospective and observational study.
Altin N; Tiğlioğlu P; Ulusoy TU; Aydin FN; Kar İ; Karakoc B; Utebey G
Medicine (Baltimore); 2024 Apr; 103(15):e37802. PubMed ID: 38608056
[TBL] [Abstract][Full Text] [Related]
2. Natural Anticoagulant Protein Levels in Patients With Beta-Thalassemia Major: A Case-Control Study.
Ahmadi A; Hosseini S; Dorgalaleh A; Hassani S; Tabibian S; Tavasoli B; Shabannezhad A; Taheri M; Shams M
J Hematol; 2024 Apr; 13(1-2):23-28. PubMed ID: 38644988
[TBL] [Abstract][Full Text] [Related]
3. Protein C and Anti-Thrombin-III Deficiency in Children With Beta-Thalassemia.
Abd El Mabood S; Fahmy DM; Akef A; El Sallab S
J Hematol; 2018 May; 7(2):62-68. PubMed ID: 32300414
[TBL] [Abstract][Full Text] [Related]
4. Strain Screening from Traditional Fermented Soybean Foods and Induction of Nattokinase Production in Bacillus subtilis MX-6.
Man LL; Xiang DJ; Zhang CL
Probiotics Antimicrob Proteins; 2019 Mar; 11(1):283-294. PubMed ID: 29411244
[TBL] [Abstract][Full Text] [Related]
5. Hemostasis during normal pregnancy and puerperium.
Hellgren M
Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
[TBL] [Abstract][Full Text] [Related]
6. Thrombin Activable Fibrinolysis Inhibitor in Beta Thalassemia.
Chhikara A; Sharma S; Chandra J; Nangia A
Indian J Pediatr; 2017 Jan; 84(1):25-30. PubMed ID: 27487812
[TBL] [Abstract][Full Text] [Related]
7. Thrombin activatable fibrinolysis inhibitor (TAFI): relationship to hemostatic alteration in patients with beta-thalassemia.
Mokhtar GM; Matter RM; Shawki H; Abdel Aziz MM
Pediatr Hematol Oncol; 2010 Aug; 27(5):363-73. PubMed ID: 20670166
[TBL] [Abstract][Full Text] [Related]
8. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.
Erem C; Nuhoglu I; Yilmaz M; Kocak M; Demirel A; Ucuncu O; Onder Ersoz H
J Endocrinol Invest; 2009 Feb; 32(2):169-74. PubMed ID: 19411818
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between plasma levels of thrombin activatable fibrinolysis inhibitor, plasminogen activator inhibitor-1 and tissue-type plasminogen activator and deep venous thrombosis in patients with systemic lupus erythematosus].
Liu YF; Hou N; Shi YJ; Li CX; Gao YJ; Liu LN
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(21):1638-1642. PubMed ID: 37248064
[No Abstract] [Full Text] [Related]
10. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism.
Erem C; Kocak M; Nuhoglu I; Yilmaz M; Ucuncu O
Eur J Endocrinol; 2009 May; 160(5):863-8. PubMed ID: 19233920
[TBL] [Abstract][Full Text] [Related]
11. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1.
Meltzer ME; Lisman T; de Groot PG; Meijers JC; le Cessie S; Doggen CJ; Rosendaal FR
Blood; 2010 Jul; 116(1):113-21. PubMed ID: 20385790
[TBL] [Abstract][Full Text] [Related]
12. Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer.
Eser M; Kement M; Balin S; Coskun C; Kefeli U; Gumus M; Altuntas YE; Kurt N; Mayadagli A
World J Surg Oncol; 2012 Aug; 10():180. PubMed ID: 22938027
[TBL] [Abstract][Full Text] [Related]
13. Subclinical central nervous system involvement and thrombophilic status in young thalassemia intermedia patients of Greek origin.
Teli A; Economou M; Rudolf J; Tzovaras F; Gourtsa V; Kondou A; Kontopoulos E; Gombakis N; Athanassiou-Metaxa M; Zafeiriou D
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):195-202. PubMed ID: 22322135
[TBL] [Abstract][Full Text] [Related]
14. Secretion and antifibrinolytic function of thrombin-activatable fibrinolysis inhibitor from human platelets.
Schadinger SL; Lin JH; Garand M; Boffa MB
J Thromb Haemost; 2010 Nov; 8(11):2523-9. PubMed ID: 20723026
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
